Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
37
XOMA Quote, Financials, Valuation and Earnings
Last price:
$26.38
Seasonality move
:
-0.13%
Day range:
$26.32 - $29.46
52-week range:
$18.35 - $39.92
Dividend yield:
0%
P/E ratio:
35.37x
P/S ratio:
9.17x
P/B ratio:
3.72x
Volume:
1.2M
Avg. volume:
446.9K
1-year change:
-3.37%
Market cap:
$326.5M
Revenue:
$28.5M
EPS (TTM):
$0.75
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $29.4M | $38.2M | $6M | $4.8M | $28.5M | |
| Revenue Growth (YoY) | 59.96% | 29.86% | -84.21% | -21.06% | 498.72% | |
| Cost of Revenues | -- | -- | $274K | $900K | $216K | |
| Gross Profit | -- | -- | $5.8M | $3.9M | $28.3M | |
| Gross Profit Margin | -- | -- | 95.45% | 81.09% | 99.24% | |
| R&D Expenses | $170K | $171K | $153K | $143K | $2.9M | |
| Selling, General & Admin | $16.8M | $20.5M | $23.2M | $25.6M | $34.5M | |
| Other Inc / (Exp) | $1.2M | -$1.2M | $295K | -$18.4M | $3.4M | |
| Operating Expenses | -$12.4M | -$17.5M | $23.2M | $25.7M | $68.2M | |
| Operating Income | $12.4M | $17.5M | -$17.4M | -$21.9M | -$40M | |
| Net Interest Expenses | $1.8M | $461K | -- | $569K | $13.8M | |
| EBT. Incl. Unusual Items | $11.8M | $15.9M | -$17.1M | -$40.8M | -$19.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.5M | $91K | -$15K | -- | -$5.7M | |
| Net Income to Company | $13.3M | $15.8M | -$17.1M | -$40.8M | -$13.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $8.9M | $12.3M | -$17.1M | -$40.8M | -$13.8M | |
| Basic EPS (Cont. Ops) | $0.82 | $0.69 | -$1.98 | -$4.04 | -$1.65 | |
| Diluted EPS (Cont. Ops) | $0.78 | $0.65 | -$1.98 | -$4.04 | -$1.65 | |
| Weighted Average Basic Share | $10.7M | $11.3M | $11.4M | $11.5M | $11.7M | |
| Weighted Average Diluted Share | $11.5M | $12.2M | $11.4M | $11.5M | $11.7M | |
| EBITDA | $12.6M | $17.7M | -$17.1M | -$21M | -$39.8M | |
| EBIT | $12.4M | $17.5M | -$17.4M | -$21.9M | -$40M | |
| Revenue (Reported) | $29.4M | $38.2M | $6M | $4.8M | $28.5M | |
| Operating Income (Reported) | $12.4M | $17.5M | -$17.4M | -$21.9M | -$40M | |
| Operating Income (Adjusted) | $12.4M | $17.5M | -$17.4M | -$21.9M | -$40M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $940K | $451K | $830K | $7.2M | $9.4M | |
| Revenue Growth (YoY) | 68.76% | -52.02% | 84.04% | 767.11% | 29.93% | |
| Cost of Revenues | -- | $47K | $224K | $3K | $880K | |
| Gross Profit | -- | $404K | $606K | $7.2M | $8.5M | |
| Gross Profit Margin | -- | 89.58% | 73.01% | 99.96% | 90.59% | |
| R&D Expenses | $30K | $29K | $25K | $817K | $69K | |
| Selling, General & Admin | $4.3M | $4.8M | $6.4M | $8M | $9.7M | |
| Other Inc / (Exp) | -$1.1M | $194K | $278K | -$12.1M | -- | |
| Operating Expenses | $3.3M | $4.8M | $6.4M | $8.8M | $9.8M | |
| Operating Income | -$3.3M | -$4.4M | -$5.8M | -$1.6M | -$1.3M | |
| Net Interest Expenses | -- | -- | -- | $3.5M | $3.3M | |
| EBT. Incl. Unusual Items | -$4.4M | -$4.2M | -$5.5M | -$17.2M | $14.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $49K | |
| Net Income to Company | -$4.4M | -$4.2M | -$5.5M | -$17.2M | $17.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4.4M | -$4.2M | -$5.5M | -$17.2M | $10.3M | |
| Basic EPS (Cont. Ops) | -$0.51 | -$0.48 | -$0.60 | -$1.59 | $0.74 | |
| Diluted EPS (Cont. Ops) | -$0.51 | -$0.48 | -$0.60 | -$1.59 | $0.70 | |
| Weighted Average Basic Share | $11.3M | $11.4M | $11.5M | $11.7M | $12.1M | |
| Weighted Average Diluted Share | $11.3M | $11.4M | $11.5M | $11.7M | $18.1M | |
| EBITDA | -$3.3M | -$4.3M | -$5.6M | -$1.6M | -$450K | |
| EBIT | -$3.3M | -$4.4M | -$5.8M | -$1.6M | -$1.3M | |
| Revenue (Reported) | $940K | $451K | $830K | $7.2M | $9.4M | |
| Operating Income (Reported) | -$3.3M | -$4.4M | -$5.8M | -$1.6M | -$1.3M | |
| Operating Income (Adjusted) | -$3.3M | -$4.4M | -$5.8M | -$1.6M | -$1.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $29.8M | $40.5M | $4.4M | $21.6M | $47.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $912K | $233K | $2.3M | |
| Gross Profit | -- | $4.4M | $3.5M | $21.4M | $44.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $165K | $167K | $146K | $2M | $2.3M | |
| Selling, General & Admin | $18.6M | $21.2M | $25.9M | $34.8M | $32.7M | |
| Other Inc / (Exp) | -$1.6M | -$354K | -$4.3M | -$3.5M | -- | |
| Operating Expenses | -$11M | -$14.8M | $25.9M | $36.8M | $65.9M | |
| Operating Income | $11M | $19.2M | -$22.4M | -$15.4M | -$21.1M | |
| Net Interest Expenses | $821K | -- | -- | $11M | $13.4M | |
| EBT. Incl. Unusual Items | $8.6M | $18.8M | -$26.7M | -$30M | $16M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $25K | $91K | -$15K | -- | -$5.6M | |
| Net Income to Company | $8.6M | $18.7M | -$26.7M | -$30M | $21.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $4.2M | $15.3M | -$26.7M | -$30M | $15.6M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.88 | -$2.81 | -$3.44 | $0.81 | |
| Diluted EPS (Cont. Ops) | -$0.02 | $0.75 | -$2.81 | -$3.48 | $0.75 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $11.2M | $19.3M | -$21.5M | -$15.2M | -$18.8M | |
| EBIT | $11M | $19.2M | -$22.4M | -$15.4M | -$21.1M | |
| Revenue (Reported) | $29.8M | $40.5M | $4.4M | $21.6M | $47.1M | |
| Operating Income (Reported) | $11M | $19.2M | -$22.4M | -$15.4M | -$21.1M | |
| Operating Income (Adjusted) | $11M | $19.2M | -$22.4M | -$15.4M | -$21.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $4.5M | $2.9M | $19.8M | $38.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $134K | $772K | $8K | $2.1M | |
| Gross Profit | -- | $4.4M | $2.2M | $19.8M | $36.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $129K | $125K | $118K | $2M | $1.4M | |
| Selling, General & Admin | $14.9M | $15.6M | $18.3M | $27.5M | $25.7M | |
| Other Inc / (Exp) | -$749K | $76K | -$4.5M | $10.3M | -$95K | |
| Operating Expenses | $12.8M | $15.6M | $18.4M | $29.5M | $27.1M | |
| Operating Income | -$12.8M | -$11.2M | -$16.2M | -$9.7M | $9.2M | |
| Net Interest Expenses | $461K | -- | -- | $10.4M | $10M | |
| EBT. Incl. Unusual Items | -$14M | -$11.1M | -$20.7M | -$9.9M | $25.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $49K | |
| Net Income to Company | -$14M | -$11.1M | -$20.7M | -$9.9M | $25.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$14M | -$11.1M | -$20.7M | -$9.9M | $19.6M | |
| Basic EPS (Cont. Ops) | -$1.53 | -$1.34 | -$2.17 | -$1.57 | $1.26 | |
| Diluted EPS (Cont. Ops) | -$1.53 | -$1.34 | -$2.17 | -$1.61 | $1.20 | |
| Weighted Average Basic Share | $33.8M | $34.2M | $34.4M | $34.9M | $36.1M | |
| Weighted Average Diluted Share | $33.8M | $34.2M | $34.4M | $40.6M | $53.7M | |
| EBITDA | -$12.7M | -$11.1M | -$15.4M | -$9.7M | $11.3M | |
| EBIT | -$12.8M | -$11.2M | -$16.2M | -$9.7M | $9.2M | |
| Revenue (Reported) | $2.2M | $4.5M | $2.9M | $19.8M | $38.4M | |
| Operating Income (Reported) | -$12.8M | -$11.2M | -$16.2M | -$9.7M | $9.2M | |
| Operating Income (Adjusted) | -$12.8M | -$11.2M | -$16.2M | -$9.7M | $9.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $85.8M | $96.2M | $58.2M | $153.6M | $106.5M | |
| Short Term Investments | -- | $774K | $335K | $161K | $3.5M | |
| Accounts Receivable, Net | $263K | $209K | $1K | $1M | $1.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $443K | $613K | $725K | $483K | $2.1M | |
| Total Current Assets | $88.1M | $97M | $61.3M | $169.3M | $125.6M | |
| Property Plant And Equipment | $380K | $213K | $36K | $403K | $351K | |
| Long-Term Investments | $36.8M | $69.1M | $63.7M | $64.1M | $64.3M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $572K | $69.4M | $63.9M | $64.6M | $69.4M | |
| Total Assets | $125.3M | $166.6M | $140.4M | $234.3M | $227M | |
| Accounts Payable | $456K | $1.1M | $524K | $653K | $1.1M | |
| Accrued Expenses | $571K | $470K | $2.4M | $1.6M | $3.9M | |
| Current Portion Of Long-Term Debt | $8.1M | -- | -- | $5.5M | $11.4M | |
| Current Portion Of Capital Lease Obligations | $179K | $195K | $34K | $54K | $446K | |
| Other Current Liabilities | $1.5M | $8.1M | $75K | $7M | $3M | |
| Total Current Liabilities | $12.3M | $13M | $6.8M | $19.5M | $24.4M | |
| Long-Term Debt | $13M | $34K | -- | $118.9M | $107.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $38.9M | $24.7M | $16.4M | $145.6M | $145M | |
| Common Stock | $84K | $85K | $86K | $86K | $90K | |
| Other Common Equity Adj | -- | -- | -- | -- | $73K | |
| Common Equity | $86.4M | $141.8M | $124M | $88.7M | $81.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $86.4M | $141.9M | $124M | $88.7M | $81.9M | |
| Total Liabilities and Equity | $125.3M | $166.6M | $140.4M | $234.3M | $227M | |
| Cash and Short Terms | $85.8M | $96.2M | $58.2M | $153.6M | $106.5M | |
| Total Debt | $21.1M | $34K | -- | $124.4M | $118.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $73.4M | $78.7M | $33.7M | $142.9M | $92M | |
| Short Term Investments | $1.2M | $443K | $214K | $785K | -- | |
| Accounts Receivable, Net | $518K | $16K | $43K | $1M | $3.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $969K | $997K | $776K | $2.4M | -- | |
| Total Current Assets | $74.9M | $79.7M | $34.5M | $159M | $110.7M | |
| Property Plant And Equipment | $255K | $81K | $5K | $369K | $296K | |
| Long-Term Investments | $55.1M | $66M | $74.7M | $58.9M | $102.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $14.5M | -- | -- | |
| Other Long-Term Assets | $55.4M | $66.3M | $75.1M | $64M | -- | |
| Total Assets | $130.5M | $146.1M | $124.1M | $223.3M | $263.2M | |
| Accounts Payable | $598K | $985K | $728K | $1.1M | $2.7M | |
| Accrued Expenses | $604K | $747K | $1.3M | $1.3M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $9.8M | -- | |
| Current Portion Of Capital Lease Obligations | $191K | $85K | -- | $434K | -- | |
| Other Current Liabilities | $1.5M | $75K | $4M | $4M | -- | |
| Total Current Liabilities | $6.5M | $5.4M | $10.3M | $21.1M | $28.3M | |
| Long-Term Debt | $85K | -- | -- | $108.7M | $115.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $18.9M | $15.8M | $18.1M | $138.5M | $155.2M | |
| Common Stock | $85K | $86K | $86K | $88K | $92K | |
| Other Common Equity Adj | -- | -- | -- | $104K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $111.6M | $130.3M | $106M | $84.8M | $108M | |
| Total Liabilities and Equity | $130.5M | $146.1M | $124.1M | $223.3M | $263.2M | |
| Cash and Short Terms | $73.4M | $78.7M | $33.7M | $142.9M | $92M | |
| Total Debt | $85K | -- | -- | $118.5M | $129.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $13.3M | $15.8M | -$17.1M | -$40.8M | -$13.8M | |
| Depreciation & Amoritzation | $172K | $167K | $274K | $900K | $216K | |
| Stock-Based Compensation | $4M | $6.2M | $3.6M | $9.1M | $10.3M | |
| Change in Accounts Receivable | $1.1M | $1.6M | $208K | -$1M | -$835K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.1M | $22.7M | -$12.9M | -$18.2M | -$14.5M | |
| Capital Expenditures | $1.2M | $26.5M | $8M | $14.7M | $20K | |
| Cash Acquisitions | -- | -- | -- | -- | $1.3M | |
| Cash From Investing | -$209K | -$26.5M | -$20.2M | -$711K | -$28.3M | |
| Dividends Paid (Ex Special Dividend) | -- | $3.5M | $5.5M | $5.5M | $5.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $130M | -- | |
| Long-Term Debt Repaid | -$5.3M | -$4.3M | -- | -- | -$6.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | $13K | |
| Other Financing Activities | -$4.3M | -$21M | -$1.4M | -$4.4M | -$4M | |
| Cash From Financing | $19.8M | $12.9M | -$4.5M | $120.6M | -$10.4M | |
| Beginning Cash (CF) | $85.8M | $95.4M | $57.8M | $153.5M | $103M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $29.7M | $9M | -$37.6M | $101.7M | -$53.1M | |
| Ending Cash (CF) | $115.5M | $104.4M | $20.3M | $255.2M | $49.9M | |
| Levered Free Cash Flow | $8.9M | -$3.8M | -$20.9M | -$32.8M | -$14.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4.4M | -$4.2M | -$5.5M | -$17.2M | $17.9M | |
| Depreciation & Amoritzation | $42K | $47K | $127K | $3K | $880K | |
| Stock-Based Compensation | $779K | $805K | $2.7M | $2.6M | $1.8M | |
| Change in Accounts Receivable | -$506K | -$11K | $858K | -$519K | -$1.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$3.1M | -$3.7M | -$2.1M | -$8.7M | -$296K | |
| Capital Expenditures | $7M | -- | -- | -- | $661K | |
| Cash Acquisitions | -- | -- | -- | -$18.9M | -$50.8M | |
| Cash From Investing | -$7M | $26K | $5.5M | $9.5M | $58.2M | |
| Dividends Paid (Ex Special Dividend) | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$3.3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $25K | |
| Other Financing Activities | -$266K | -$360K | -- | -$1.1M | -- | |
| Cash From Financing | -$1.5M | -$1.3M | -$1.4M | -$3.9M | -$5.8M | |
| Beginning Cash (CF) | $72.2M | $78.3M | $33.5M | $142.1M | $90.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$11.6M | -$4.9M | $2M | -$3.1M | $52.1M | |
| Ending Cash (CF) | $60.6M | $73.4M | $35.5M | $139M | $142.5M | |
| Levered Free Cash Flow | -$10.1M | -$3.7M | -$2.1M | -$8.7M | -$957K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.6M | $18.7M | -$26.7M | -$30M | $21.6M | |
| Depreciation & Amoritzation | $166K | $176K | $815K | $233K | $2.3M | |
| Stock-Based Compensation | $5.1M | $4.4M | $7.4M | $10.8M | $7.5M | |
| Change in Accounts Receivable | $1.1M | $502K | -$27K | -$1M | -$2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.7M | $21.7M | -$18.1M | -$15.5M | $5.4M | |
| Capital Expenditures | $21.7M | $6M | $8M | $14.7M | $21.3M | |
| Cash Acquisitions | -- | -- | -- | -$18.9M | -$30.6M | |
| Cash From Investing | -$20.7M | -$11M | -$21.5M | $13.7M | -$4.9M | |
| Dividends Paid (Ex Special Dividend) | $2.1M | $5.5M | $5.5M | $5.5M | $5.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$6.4M | -- | -- | -$6.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | $13K | $2.4M | |
| Other Financing Activities | -$25M | -$1.5M | -- | -$7.6M | -- | |
| Cash From Financing | $37.5M | -$4.6M | -$5.2M | $115.2M | -$16.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $26.4M | $6.1M | -$44.8M | $113.3M | -$16.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$12M | $15.7M | -$26.1M | -$30.2M | -$15.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$14M | -$11.1M | -$20.7M | -$9.9M | $25.6M | |
| Depreciation & Amoritzation | $125K | $134K | $675K | $8K | $2.1M | |
| Stock-Based Compensation | $4.4M | $2.6M | $6.5M | $8.1M | $5.4M | |
| Change in Accounts Receivable | $1.3M | $193K | -$42K | -$41K | -$1.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$8M | -$9M | -$14.2M | -$11.6M | $8.3M | |
| Capital Expenditures | $20.5M | -- | -- | $17K | $21.3M | |
| Cash Acquisitions | -- | -- | -- | -$18.9M | -$50.8M | |
| Cash From Investing | -$20.5M | -$5M | -$6.2M | $8.2M | $31.5M | |
| Dividends Paid (Ex Special Dividend) | $2.1M | $4.1M | $4.1M | $4.1M | $4.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$4.3M | -- | -- | -$6.9M | -$5.1M | |
| Repurchase of Common Stock | -- | -- | -- | $13K | $2.4M | |
| Other Financing Activities | -$20.9M | -$1.4M | -$5K | -$3.2M | -$240K | |
| Cash From Financing | $14.3M | -$3.1M | -$3.9M | -$9.3M | -$15.7M | |
| Beginning Cash (CF) | $225.9M | $250.1M | $109.2M | $422.4M | $257.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$14.2M | -$17.1M | -$24.4M | -$12.7M | $24.1M | |
| Ending Cash (CF) | $211.7M | $233M | $84.9M | $409.7M | $281.4M | |
| Levered Free Cash Flow | -$28.5M | -$9M | -$14.2M | -$11.6M | -$13M | |
Get XOMA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XOMA
Sector
P/E ratio
35.37x
23.89x
PEG ratio
-0.25x
-0.01x
P/B ratio
3.72x
1.81x
Price / LTM sales
9.17x
1.59x
Growth Metrics
XOMA
Sector
Revenue growth
29.93%
4.35%
Earnings growth
144%
9.8%
Revenue (5-year growth)
9.17%
6.41%
Earnings forecast
-$0.09
-$0.18
Profitability
XOMA
Sector
Profitability FY 2024
$28.3M
$3.2M
Return on invested capital
7.44%
-32.76%
Return on assets
6.8%
-29.32%
Return on equity
17.31%
-38.6%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
17
Estimated Next Earnings Date
Feb
11
Balance Sheet
XOMA
Sector
Total cash
$92M
$25.4M
Short term investments
$3.5M
$25.1M
Total assets
$227M
$74.7M
Long term debt
$129.4M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
